← Back to patent-cliff list
6-[18F]Fluorodopa
Tier C — Watch / trade6-[18F]Fluorodopa
诺华制药
Originator
2016
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Not applicable
Brand：IASOdopa
Indications (approved)：帕金森综合征、诊断剂
Regional status
US
批准上市
2019-10-10
EU
批准上市
2016-11-01
China
临床三期
2024-11-15
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of 6-[18F]Fluorodopa?
Approved indications include: 帕金森综合征, 诊断剂.
When does the 6-[18F]Fluorodopa patent expire?
No public expiry year is available for 6-[18F]Fluorodopa yet; this page updates once verified.
How do I get a quote for 6-[18F]Fluorodopa intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24